Dose-volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation.

Published on Jan 1, 2016in Radiotherapy and Oncology4.856
· DOI :10.1016/J.RADONC.2015.11.020
Carla Sini9
Estimated H-index: 9
,
C. Fiorino7
Estimated H-index: 7
+ 9 AuthorsCesare Cozzarini43
Estimated H-index: 43
Sources
Abstract
Abstract Purpose To prospectively identify clinical/dosimetric predictors of acute/late hematologic toxicity (HT) in chemo-naIve patients treated with whole-pelvis radiotherapy (WPRT) for prostate cancer. Material and methods Data of 121 patients treated with adjuvant/salvage WPRT were analyzed (static-field IMRT n =19; VMAT/Rapidarc n =57; Tomotherapy n =45). Pelvic bone marrow (BM) was delineated as ilium (IL), lumbosacral, lower and whole pelvis (WP), and the relative DVHs were calculated. HT was graded both according to CTCAE v4.03 and as variation in percentage relative to baseline. Logistic regression was used to analyze association between HT and clinical/DVHs factors. Results Significant differences ( p p ⩽0.001). Higher BM V40 was associated with higher risk of acute Grade3 (OR=1.018) or late Grade2 lymphopenia (OR=1.005). Two models predicting lymphopenia were developed, both including baseline ALC, and BM WP-V40 (AUC=0.73) and IL-V40+smoking (AUC=0.904) for acute/late respectively. Conclusions Specific regions of pelvic BM predicting acute/late lymphopenia, a risk factor for viral infections, were identified. The 2-variable models including specific constraints to BM may help reduce HT.
📖 Papers frequently viewed together
275 Citations
2 Citations
171 Citations
References13
Newest
#1Aaron T. Wild (Johns Hopkins University)H-Index: 20
#2Xiaobu Ye (Johns Hopkins University)H-Index: 35
Last. Joseph M. HermanH-Index: 78
view all 13 authors...
Objectives Lymphopenia is a common consequence of chemoradiation therapy yet is seldom addressed clinically. This study was conducted to determine if patients with locally advanced pancreatic cancer (LAPC) treated with definitive chemoradiation develop significant lymphopenia and if this affects clinical outcomes.
106 CitationsSource
#1T. Jonathan Yang (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 17
#2Jung Hun Oh (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 26
Last. Karyn A. Goodman (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 57
view all 6 authors...
Background and purpose To identify clinical and dosimetric factors associated with hematologic toxicity (HT) during chemoradiotherapy for rectal cancer.
28 CitationsSource
#1Chad Tang (University of Texas MD Anderson Cancer Center)H-Index: 32
#2Zhongxing Liao (University of Texas MD Anderson Cancer Center)H-Index: 87
Last. James Welsh (University of Texas MD Anderson Cancer Center)H-Index: 43
view all 9 authors...
Purpose Radiation therapy (RT) can both suppress and stimulate the immune system. We sought to investigate the mechanisms underlying radiation-induced lymphopenia and its associations with patient outcomes in non-small cell lung cancer (NSCLC). Methods and Materials Subjects consisted of 711 patients who had received definitive RT for NSCLC. A lymphocyte nadir was calculated as the minimum lymphocyte value measured during definitive RT. Associations between gross tumor volumes (GTVs) and lung do...
150 CitationsSource
#1V. CarilloH-Index: 9
#2Cesare CozzariniH-Index: 43
Last. Claudio FiorinoH-Index: 54
view all 20 authors...
Background and purpose: DUE01 is an observational study aimed at developing predictive models of genito-urinary toxicity of patients treated for prostate cancer with conventional (1.8–2 Gy/fr, CONV) or moderate hypo-fractionation (2.35–2.7 Gy/fr, HYPO). The current analysis focused on the relationship between bladder DVH/DSH and the risk of International Prostate Symptoms Score (IPSS) P 15/20 at the end of radiotherapy.
33 CitationsSource
113k Citations
#1Ann H. Klopp (University of Texas MD Anderson Cancer Center)H-Index: 31
#2Jennifer MoughanH-Index: 32
Last. Anuja Jhingran (University of Texas MD Anderson Cancer Center)H-Index: 42
view all 12 authors...
Purpose Intensity modulated radiation therapy (IMRT), compared with conventional 4-field treatment, can reduce the volume of bone marrow irradiated. Pelvic bone marrow sparing has produced a clinically significant reduction in hematologic toxicity (HT). This analysis investigated HT in Radiation Therapy Oncology Group (RTOG) 0418, a prospective study to test the feasibility of delivering postoperative IMRT for cervical and endometrial cancer in a multiinstitutional setting. Methods and Materials...
102 CitationsSource
#1Susannah G. Yovino (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 2
#2Lawrence KleinbergH-Index: 39
Last. Eric Ford (Johns Hopkins University)H-Index: 60
view all 5 authors...
Purpose: Severe treatment-related lymphopenia (TRL) occurs in 40% of patients with high grade gliomas (HGG) receiving glucocorticoids, temozolomide, and radiation. This occurs following radiation, persists for months, and is associated with reduced survival. As all three treatment modalities are lymphotoxic, this study was conducted to estimate the radiation dose that lymphocytes receive passing through the radiation field and if this could explain the observed TRL. Materials and Methods: A typi...
171 CitationsSource
#1Kevin Albuquerque (Loyola University Medical Center)H-Index: 17
#2David Giangreco (LUC: Loyola University Chicago)H-Index: 1
Last. John C. Roeske (LUC: Loyola University Chicago)H-Index: 37
view all 7 authors...
Purpose To determine factors predictive for hematologic toxicity (HT) associated with concurrent chemoradiation for Stage II through IV cervical cancer. Methods and Materials The medical records of 40 women receiving concurrent chemoradiation for cervical cancer were reviewed. Hematologic toxicity was defined by use of Common Terminology Criteria for Adverse Events (version 3.0). Variables predicting for HT including age, body mass index, transfusions, and bone marrow volumes irradiated were inc...
80 CitationsSource
#1Michael T. Spiotto (Stanford University)H-Index: 21
#2Steven L. Hancock (Stanford University)H-Index: 50
Last. Christopher R. King (Stanford University)H-Index: 37
view all 3 authors...
Purpose: To compare the biochemical relapse-free survival (bRFS) among patients receiving whole pelvic radiotherapy (WPRT) vs. prostate bed RT (PBRT) after radical prostatectomy. Methods and Materials: Between 1985 and 2005, 160 patients underwent adjuvant or salvage RT after radical prostatectomy. A short course of total androgen suppression was also given concurrently to 87 patients. Of the 160 patients, 114 were considered at high risk of lymph node involvement because they had a pathologic G...
173 CitationsSource
#1Cesare CozzariniH-Index: 43
#2C. FiorinoH-Index: 7
Last. Ferruccio Fazio (University of Milano-Bicocca)H-Index: 78
view all 10 authors...
Abstract Purpose To assess and quantify the possible benefit deriving from IMRT with Helical Tomotherapy (HTT) delivery to the pelvic nodal area in patients with prostate cancer in terms of reduction of acute and late toxicities. Methods and materials Thirty-five patients candidate to radical or postoperative RT on whole pelvis (WPRT) were treated with HTT, while receiving a concomitant boost to the prostate or the prostatic bed (median 74.2 and 72Gy, respectively) within a moderately hypofracti...
92 CitationsSource
Cited By24
Newest
#1Fernando Munoz (AUSL: Academy for Urban School Leadership)H-Index: 11
#2Giuseppe SanguinetiH-Index: 37
Last. A. FaiellaH-Index: 5
view all 0 authors...
Background: Baseline urinary incontinence (UI) strongly modulates UI recovery after adjuvant/salvage radiotherapy (ART/SRT), inducing clinicians to postpone it “as much as possible”, maximizing UI recovery but possibly reducing efficacy. This series aims to analyze the trend of UI recovery and its predictors at radiotherapy start. Methods: A population of 408 patients treated with ART/SRT enrolled in a cohort study (ClinicalTrials.gov #NCT02803086) aimed at developing predictive models of radiat...
Source
#1David S. Lakomy (University of Texas MD Anderson Cancer Center)H-Index: 3
#2Juliana Wu (University of Texas at Austin)
Last. Lilie L. Lin (University of Texas MD Anderson Cancer Center)H-Index: 10
view all 0 authors...
Background null Immune markers have been correlated with prognosis in a variety of solid tumors, including cervical cancer. null Objective null To review the literature on hematologic and immune markers and their association with recurrence and survival among patients with cervical cancer treated with chemoradiation. null Evidence review null This systematic review was conducted in accordance with PRISMA guidelines via searches of Ovid MEDLINE, Ovid Embase, and the Cochrane Library using keyword...
Source
#1Cynthia Terrones-Campos (UCPH: University of Copenhagen)H-Index: 1
#2B Ledergerber (UCPH: University of Copenhagen)H-Index: 10
Last. Jens D. Lundgren (UCPH: University of Copenhagen)H-Index: 114
view all 6 authors...
PURPOSE To describe the kinetics of the peripheral blood components after radiotherapy, to examine radiation exposure vs. End-of-Radiation-Therapy (EoRT) counts and to associate the EoRT lymphocyte count with death and cancer treatment failure. MATERIALS AND METHODS Cohort study of patients who received curative intent radiotherapy for solid tumor diagnoses from 2009-2016 at Rigshospitalet, Copenhagen and had available 3D radiation exposure data. We illustrated peripheral blood count kinetics wi...
Source
#1Andrea BresolinH-Index: 1
#2A. FaiellaH-Index: 5
Last. Cesare CozzariniH-Index: 43
view all 24 authors...
Abstract Background and purpose To assess bowel dose-volume relationships for acute patient-reported intestinal symptoms of patients treated with whole-pelvis intensity-modulated radiotherapy (WPRT) for prostate cancer. Materials and methods Complete data of 415 patients enrolled in a multi institute, prospective trial (#NCT02803086) treated with radical (31%), adjuvant (33%) and salvage (36%) intent at a median dose to pelvic nodes/lymph-nodal area of 53Gy were available. The most severe change...
Source
Resume La moelle osseuse pelvienne est le siege de pres de 50 % de l’hematopoiese totale. La radiotherapie des aires ganglionnaires pelviennes, et des cancers situes a proximite des structures osseuses du bassin, expose a une toxicite hematologique de l’ordre de 30 a 70 %. Cette toxicite depend de nombreux facteurs, notamment la delivrance ou non d’une chimiotherapie concomitante, ainsi que de son type, des volumes osseux irradies, des doses recues, ou encore de la reserve hematopoietique initia...
Source
#1Ivica RatosaH-Index: 4
#2Miha Orazem (Katholieke Universiteit Leuven)
Last. Icro Meattini (UniFI: University of Florence)H-Index: 22
view all 12 authors...
Abstract Background and purpose: The cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) represent the standard treatment for hormone receptor positive, human epidermal growth factor receptor 2 negative metastatic breast cancer (MBC). Data regarding toxicity safety profiles when combining CDK4/6i with palliative radiotherapy (RT) are lacking. Material and methods We undertook a review of 46 MBC patients on systemic treatment with CDK4/6i who underwent 62 metastases-directed RT. Clinical, labora...
Source
#2Umberto RicardiH-Index: 52
Last. Alan Dal PraH-Index: 15
view all 3 authors...
Source
#1Jin Huang (PRC: China Medical University (PRC))H-Index: 2
#2Fei Gu (PRC: China Medical University (PRC))H-Index: 1
Last. Guang Li (PRC: China Medical University (PRC))H-Index: 11
view all 5 authors...
To test the efficacy and feasibility of pelvic bone marrow sparing intensity modulated radiotherapy (PBMS-IMRT) in reducing grade 2 or higher hematological toxicity (HT2+) for patients with cervical cancer treated with concurrent chemoradiotherapy. A total of 164 patients with Stage Ib2–IIIb cervical cancer were prospectively enrolled from March 2018 to March 2019 at a single center and were randomly allocated into the PBMS group or the control group. The control group received weekly cisplatin ...
1 CitationsSource
#1Andrea Bresolin (UniSR: Vita-Salute San Raffaele University)H-Index: 1
Last. Cesare Cozzarini (UniSR: Vita-Salute San Raffaele University)
view all 20 authors...
Objective. To investigate predictors of patient-reported urinary incontinence (PRUI) in the first 2 years after post-prostatectomy radiotherapy (PORT) with particular emphasis on possible dose-effect relationships. Patients and Methods. Two-hundred-thirteen patients, whose clinical and dosimetric data were prospectively collected within a registered multi-institutional cohort study, underwent PORT with adjuvant (n=106) or salvage (n=107) intent with conventional (n=123, prescribed dose to the pr...
Source
#1Łukasz Kuncman (Medical University of Łódź)H-Index: 1
#2Konrad Stawiski (Medical University of Łódź)H-Index: 7
Last. Jacek Fijuth (Medical University of Łódź)H-Index: 1
view all 5 authors...
PURPOSE Magnetic resonance imaging (MRI) is routinely used for locoregional staging of rectal cancer and offers promise for the prediction of hematologic toxicity. The present study compares the clinical utility of MRI-based active bone marrow (BMact) delineation with that of CT-based bone marrow total (BMtot) delineation for predicting hematologic toxicity. METHODS A prospective cohort study was performed. Eligible patients had stage II/III rectal cancer and qualified for preoperative chemoradi...
Source